Forian turns Q2 profit as Kyber boosts revenue; $35.6M cash but Sep note looms

Forian Inc. (NASDAQ: FORA) - Quick take

What's happening: Forian closed the Kyber acquisition (Oct 31, 2024) and that deal is driving most of the revenue growth in 2025. The company moved from a loss-making comparable quarter in 2024 to a small GAAP profit in Q2 2025 while retaining a sizable cash + short-term investments balance. Management is addressing vendor-licensing disruption and historical internal control weaknesses; remediation work is underway.

Key facts & stats (as reported)

* Revenue (Q2 2025): $7,476,140 vs Q2 2024: $4,777,101 (increase $2.699M)

* Revenue (6M 2025): $14,532,256 vs 6M 2024: $9,654,479

* Net income (Q2 2025): $224,793 vs Q2 2024: $(2,553,259)

* Net loss (6M 2025): $(901,069) vs 6M 2024: $(3,765,874)

* Operating income (Q2 2025): $46,076 (Q2 2024: $(2,970,478))

* Adjusted EBITDA (Q2 2025): $591,073 vs Q2 2024: $78,202

* Gross margin (Q2 2025): 57% (Q2 2024: 62%); 6M margin 56% vs 64%

* Cash & marketable securities (6/30/2025): $5,369,817 + $30,279,208 = $35,649,025

* Total assets (6/30/2025): $48,462,637; Total stockholders' equity: $30,941,661

* Convertible notes payable, net (6/30/2025): $6,804,016 (principal outstanding $6,000,000)

* Accounts receivable, net: $5,267,632; Contract assets: $2,666,627; Deferred revenue: $4,911,427

* Intangible assets, net: $1,097,741 (customer relationships + tradenames)

* Shares outstanding (as disclosed): 31,112,312 (as of Aug 13, 2025); 31,202,312 issued/outstanding (6/30/2025)

* Customer concentration: one customer = 11.4% of revenue (Q2 2025); AR concentrations: 18.5%, 17.3%, 10.4%

* Vendor concentration: two vendors = 21.3% and 12.7% of purchases (Q2 2025)

* Future minimum service/license payments (remaining): $12,701,625 total (multi‑year schedule)

Positive items - income statement & operating

* Strong top-line growth: Revenues up materially year-over-year (Q2 +56%), driven by Kyber and organic sales.

* GAAP improvement: Turned a large prior-year loss into a modest Q2 net income ($224,793) and positive operating income ($46,076).

* Adjusted EBITDA improvement: Q2 Adjusted EBITDA jumped to $591k from $78k - operating leverage despite higher costs.

* Litigation drag removed: Litigation settlements and related expenses fell to $0 in Q2 (vs ~$942k in Q2 2024), helping margins.

* Healthy liquid position: $35.65M in cash + U.S. Treasury bills provides runway for operations or M&A opportunities.

Negative items - income statement & risks

* Gross margin compression: Cost of revenues rose faster than revenue - gross margin fell to 57% (Q2 2024: 62%). Higher info licensing / processing costs and Kyber integration effects contributed.

* Continued net loss year-to-date: Six-months loss of $(901,069) despite Q2 profit - volatility remains.

* Large non-cash stock-based expense: $1.95M for six months (Q2: $661,502) - significant dilutionary compensation; $4,283,136 unrecognized stock comp remains.

* Customer & vendor concentration: Top customers and a couple of vendors represent material portions of revenue and expenses - loss of a major customer or vendor disruption could be material.

* Vendor licensing risk: A key vendor is exiting data licensing (announced Feb 2025); company recorded a $175k benefit in Q2 and previously a $542,389 adjustment in 2024. Replacement data sources may be costly or unavailable.

* Debt maturity: Convertible notes outstanding ($6.0M principal; net $6,804,016) mature Sep 1, 2025 - potential refinancing, conversion or cash outlay risk near term.

* Accumulated deficit: $(50,816,179) - the company must sustain profitability or access capital to de-lever over time.

* Internal controls: Material weaknesses in internal controls were disclosed; remediation actions are in progress but not yet fully effective.

Other material items

* Kyber acquisition: Recorded a bargain purchase gain historically and Kyber contributed revenues of $1,859,566 (Q2 2025) and $3,552,913 (6M 2025).

* Investment income down: Interest & investment income fell (Q2 2025: $347,968 vs Q2 2024: $618,316) as treasury bill balances and yields changed.

* Contracted backlog / remaining performance obligations: $31,184,753 (estimated future revenue: $20,493,348 next 12 months)

What to watch next (near-term catalysts & risks)

* Convertible note outcome by Sep 1, 2025 - redemption, conversion, or refinancing will materially affect cash, dilution or leverage.

* Replacement/licensing of third-party data: speed and cost to secure equivalent data will impact future cost of revenues and product competitiveness.

* Execution on control remediation: auditors/management testing results - lingering weaknesses could affect reporting trust and access to capital.

* Revenue mix and customer retention: monitor whether growth is sustainable beyond Kyber contribution and whether top customers renew/expand.

Bottom line: Forian shows clear revenue acceleration and a meaningful quarter-over-quarter operating improvement largely tied to the Kyber deal and lower legacy litigation. Liquidity is strong, but margin pressure from higher licensing/processing costs, vendor dependency, elevated stock-based compensation and a near-term convertible note maturity create material execution and financing risks. Close attention to the Sep 2025 note outcome, vendor replacements and control remediation is essential.